Lee SS. Post-laparotomy heterotopic ossification of the xiphoid process: A case report. World J Clin Cases 2023; 11(36): 8568-8573 [PMID: 38188202 DOI: 10.12998/wjcc.v11.i36.8568]
Corresponding Author of This Article
Seung Soo Lee, MD, PhD, Associate Professor, Surgical Oncologist, Department of Surgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, South Korea. peterleess@knu.ac.kr
Research Domain of This Article
Surgery
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Dec 26, 2023; 11(36): 8568-8573 Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8568
Post-laparotomy heterotopic ossification of the xiphoid process: A case report
Seung Soo Lee
Seung Soo Lee, Department of Surgery, Kyungpook National University Hospital, Daegu 41944, South Korea
Seung Soo Lee, Department of Surgery, School of Medicine, Kyungpook National University, Daegu 41944, South Korea
Author contributions: Lee SS contributed to conceptualization, design of the study, acquisition and analysis of data, drafting and revising the manuscript, and final approval of the version to be submitted.
Informed consent statement: The patient provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Seung Soo Lee, MD, PhD, Associate Professor, Surgical Oncologist, Department of Surgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, South Korea. peterleess@knu.ac.kr
Received: October 16, 2023 Peer-review started: October 16, 2023 First decision: November 21, 2023 Revised: November 24, 2023 Accepted: December 13, 2023 Article in press: December 13, 2023 Published online: December 26, 2023 Processing time: 67 Days and 0 Hours
Core Tip
Core Tip: Heterotopic ossification (HO) represents all types of extraskeletal ossification, and occurs in various areas, including the skin, muscle, and joints. There are some suggested treatment and preventive approaches for symptomatic HO, which include surgical excision and preventive measures such as postoperative radiotherapy, oral nonsteroidal anti-inflammatory drugs, and topical sealants (bone wax). However, these recommendations are based on personal experiences limited to HO in certain locations. It is important to individualize our treatment approaches depending on its location. For symptomatic HO along the laparotomy scar, complete surgical excision should be the priority treatment option, and bone wax application is not recommended.
